These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29845742)

  • 1. Selective CXCR4
    Díaz R; Pallarès V; Cano-Garrido O; Serna N; Sánchez-García L; Falgàs A; Pesarrodona M; Unzueta U; Sánchez-Chardi A; Sánchez JM; Casanova I; Vázquez E; Mangues R; Villaverde A
    Small; 2018 Jun; 14(26):e1800665. PubMed ID: 29845742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination.
    Pallarès V; Unzueta U; Falgàs A; Sánchez-García L; Serna N; Gallardo A; Morris GA; Alba-Castellón L; Álamo P; Sierra J; Villaverde A; Vázquez E; Casanova I; Mangues R
    J Hematol Oncol; 2020 Apr; 13(1):36. PubMed ID: 32295630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective delivery of T22-PE24-H6 to CXCR4
    Falgàs A; Pallarès V; Serna N; Sánchez-García L; Sierra J; Gallardo A; Alba-Castellón L; Álamo P; Unzueta U; Villaverde A; Vázquez E; Mangues R; Casanova I
    Theranostics; 2020; 10(12):5169-5180. PubMed ID: 32373205
    [No Abstract]   [Full Text] [Related]  

  • 4. Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4.
    Pallarès V; Núñez Y; Sánchez-García L; Falgàs A; Serna N; Unzueta U; Gallardo A; Alba-Castellón L; Álamo P; Sierra J; Villaverde A; Vázquez E; Casanova I; Mangues R
    J Control Release; 2021 Jul; 335():117-129. PubMed ID: 34004204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4
    Sala R; Sánchez-García L; Serna N; Céspedes MV; Casanova I; Roldán M; Sánchez-Chardi A; Unzueta U; Vázquez E; Mangues R; Villaverde A
    Acta Biomater; 2019 Nov; 99():426-432. PubMed ID: 31494293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma.
    Rioja-Blanco E; Arroyo-Solera I; Álamo P; Casanova I; Gallardo A; Unzueta U; Serna N; Sánchez-García L; Quer M; Villaverde A; Vázquez E; León X; Alba-Castellón L; Mangues R
    J Exp Clin Cancer Res; 2022 Feb; 41(1):49. PubMed ID: 35120582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4
    Falgàs A; Garcia-León A; Núñez Y; Serna N; Sánchez-Garcia L; Unzueta U; Voltà-Durán E; Aragó M; Álamo P; Alba-Castellón L; Sierra J; Gallardo A; Villaverde A; Vázquez E; Mangues R; Casanova I
    Biomed Pharmacother; 2022 Jun; 150():112940. PubMed ID: 35421785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective depletion of metastatic stem cells as therapy for human colorectal cancer.
    Céspedes MV; Unzueta U; Aviñó A; Gallardo A; Álamo P; Sala R; Sánchez-Chardi A; Casanova I; Mangues MA; Lopez-Pousa A; Eritja R; Villaverde A; Vázquez E; Mangues R
    EMBO Mol Med; 2018 Oct; 10(10):. PubMed ID: 30190334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruiting potent membrane penetrability in tumor cell-targeted protein-only nanoparticles.
    Serna N; Sánchez JM; Unzueta U; Sánchez-García L; Sánchez-Chardi A; Mangues R; Vázquez E; Villaverde A
    Nanotechnology; 2019 Mar; 30(11):115101. PubMed ID: 30561375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse model.
    Pallarès V; Unzueta U; Falgàs A; Aviñó A; Núñez Y; García-León A; Sánchez-García L; Serna N; Gallardo A; Alba-Castellón L; Álamo P; Sierra J; Cedó L; Eritja R; Villaverde A; Vázquez E; Casanova I; Mangues R
    Biomaterials; 2022 Jan; 280():121258. PubMed ID: 34847435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs.
    Sánchez-García L; Serna N; Álamo P; Sala R; Céspedes MV; Roldan M; Sánchez-Chardi A; Unzueta U; Casanova I; Mangues R; Vázquez E; Villaverde A
    J Control Release; 2018 Mar; 274():81-92. PubMed ID: 29408658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models.
    Medina-Gutiérrez E; García-León A; Gallardo A; Álamo P; Alba-Castellón L; Unzueta U; Villaverde A; Vázquez E; Casanova I; Mangues R
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4
    Céspedes MV; Unzueta U; Álamo P; Gallardo A; Sala R; Casanova I; Pavón MA; Mangues MA; Trías M; López-Pousa A; Villaverde A; Vázquez E; Mangues R
    Nanomedicine; 2016 Oct; 12(7):1987-1996. PubMed ID: 27085904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles.
    Unzueta U; Céspedes MV; Ferrer-Miralles N; Casanova I; Cedano J; Corchero JL; Domingo-Espín J; Villaverde A; Mangues R; Vázquez E
    Int J Nanomedicine; 2012; 7():4533-44. PubMed ID: 22923991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo.
    Núñez Y; Garcia-León A; Falgàs A; Serna N; Sánchez-García L; Garrido A; Sierra J; Gallardo A; Unzueta U; Vázquez E; Villaverde A; Mangues R; Casanova I
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4
    Rioja-Blanco E; Arroyo-Solera I; Álamo P; Casanova I; Gallardo A; Unzueta U; Serna N; Sánchez-García L; Quer M; Villaverde A; Vázquez E; Mangues R; Alba-Castellón L; León X
    Acta Pharm Sin B; 2022 May; 12(5):2578-2591. PubMed ID: 35646535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases.
    Sala R; Rioja-Blanco E; Serna N; Sánchez-García L; Álamo P; Alba-Castellón L; Casanova I; López-Pousa A; Unzueta U; Céspedes MV; Vázquez E; Villaverde A; Mangues R
    Drug Deliv; 2022 Dec; 29(1):1384-1397. PubMed ID: 35532120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured toxins for the selective destruction of drug-resistant human CXCR4
    Serna N; Álamo P; Ramesh P; Vinokurova D; Sánchez-García L; Unzueta U; Gallardo A; Céspedes MV; Vázquez E; Villaverde A; Mangues R; Medema JP
    J Control Release; 2020 Apr; 320():96-104. PubMed ID: 31931052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles.
    Álamo P; Pallarès V; Céspedes MV; Falgàs A; Sanchez JM; Serna N; Sánchez-García L; Voltà-Duràn E; Morris GA; Sánchez-Chardi A; Casanova I; Mangues R; Vazquez E; Villaverde A; Unzueta U
    Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33105866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines.
    Álamo P; Cedano J; Conchillo-Sole O; Cano-Garrido O; Alba-Castellon L; Serna N; Aviñó A; Carrasco-Diaz LM; Sánchez-Chardi A; Martinez-Torró C; Gallardo A; Cano M; Eritja R; Villaverde A; Mangues R; Vazquez E; Unzueta U
    Acta Biomater; 2021 Aug; 130():211-222. PubMed ID: 34116228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.